A comprehensive view of Branded Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

BIOGEN INC. - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published: April 24, 2024 by SEC Edgar Filings
U.S. Patent and Trademark Office Receives Regeneron Pharmaceuticals's Patent Application for Vegf Traps and Mini-Traps and Methods for Treating Ocular Disorders and Cancer
Published: April 22, 2024 by Pharmaceutical Patent News
European Commission approves Jannsen's CARVYKTI ciltacabtagene autoleucel cilta-cel for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy; it is the first BCMA-targeted treatment approved by the EC
Published: April 22, 2024 by Janssen Pharmaceutical Companies
Patent Issued for Protein solution formulation containing high concentration of an anti-VEGF antibody (USPTO 11945859)
Published: April 19, 2024 by Angiogenesis Daily
US Dept. of Justice files complaint alleging fraudulent drug pricing practices by Regeneron for its ophthalmology drug Eylea that cost Medicare hundreds of millions of dollars
Published: April 12, 2024 by Zack's Commentary

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count